{"nctId":"NCT00088153","briefTitle":"Effects of Anorexia Nervosa on Bone Mass in Adolescents","startDateStruct":{"date":"2003-07"},"conditions":["Anorexia Nervosa"],"count":110,"armGroups":[{"label":"Physiologic estrogen replacement","type":"EXPERIMENTAL","interventionNames":["Drug: Physiologic Estrogen/progesterone"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Other: Placebo"]}],"interventions":[{"name":"Physiologic Estrogen/progesterone","otherNames":["Bone age >=15: Vivelle Dot patch with cyclic Provera"]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Females Only with Anorexia Nervosa and Amenorrhea 12-18 years\n* Normal-weight girls 12-18 years with no past or present history of an eating disorder\n\nExclusion Criteria:\n\n* Diseases affecting bone metabolism (including untreated thyroid disease, premature ovarian failure, diabetes, cancer, pituitary, renal disease or bone fracture within the past six months)\n* Use of prescription medications affecting bone metabolism within three months\n* Suicidality\n* Psychosis\n* Substance abuse\n* Hematocrit \\<30 %\n* Potassium \\<3.0 mmol/L\n* Glucose \\<50 mg/dl.","healthyVolunteers":true,"sex":"FEMALE","minimumAge":"12 Years","maximumAge":"18 Years","stdAges":["CHILD","ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Percent Change in Spine Bone Density Over the Study Duration (18 Months)","description":"Bone density at the spine (lumbar 1-4 vertebrae) was measured using dual energy x-ray absorptiometry (DXA) at baseline, 6 months, 12 months and 18 months.\n\nThe primary outcome was the percent change in bone density at the spine from baseline to 18 months. Areal bone density is measured as g/cm2. The unit of measure for the percent change in bone density is 'percent' Percent change in bone density= \\[\\[Bone density at 18 months- Bone density at baseline)\\*100/Bone density at baseline\\]%","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.6","spread":"1.0"},{"groupId":"OG001","value":"0.3","spread":"0.1"}]}]}]},{"type":"SECONDARY","title":"Change in N-terminal Propeptide of Type 1 Procollagen (P1NP) Over the Study Duration (18 Months)","description":"P1NP is a surrogate marker of bone formation that is measured in serum. P1NP levels were measured at baseline, 6, 12 and 18 months.\n\nA secondary outcome was the change in P1NP levels from baseline to 18 months: \\[P1NP at 18 months - P1NP at baseline). The unit is ng/ml","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.9","spread":"22.5"},{"groupId":"OG001","value":"-10.9","spread":"27.0"}]}]}]},{"type":"PRIMARY","title":"Change in Spine Bone Mineral Density Z-scores Over the Study Duration (18 Months)","description":"Bone density at the spine (lumbar 1-4 vertebrae) was measured using dual energy x-ray absorptiometry (DXA) at baseline, 6 months, 12 months and 18 months.\n\nThe other primary outcome was the change in spine bone density Z-score from baseline to 18 months. The bone density Z-score is a standard deviation score that compares one's bone density to the mean for age and gender, and the Z-score, therefore, does not have any units. It is simply referred to as a Z-score. Change in bone density Z-score= \\[Bone density Z-score at 18 months- Bone density Z-score at baseline\\]","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.026","spread":"0.078"},{"groupId":"OG001","value":"-0.236","spread":"0.091"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":12,"n":55},"commonTop":["Erythema at patch application site","Bloating","Headaches","Breast tenderness","Nausea/vomiting"]}}}